CLNN
CLNN
NASDAQ · Biotechnology

Clene Inc

$4.29
+0.37 (+9.44%)
As of Feb 8, 2:18 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 27.73M 28.89M 22.68M
Net Income 2.46M 2.55M 2.38M
EPS
Profit Margin 8.9% 8.8% 10.5%
Rev Growth +8.3% +0.1% +7.6%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 23.17M 25.17M 22.41M
Total Equity 40.88M 35.16M 34.69M
D/E Ratio 0.57 0.72 0.65
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA 4.02M 4.88M 3.72M
Free Cash Flow 2.55M 2.44M 2.81M